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The expression of Vitreoscilla hemoglobin (VHb) in Escherichia coli JM101(pRED2) causes the incorporation
of the TEM 13-lactamase precursor into cytoplasmic inclusion bodies (IBs). Less pre-I8-lactamase is translocated
and processed to its mature, periplasmic form in the strain coexpressing VHb than in the control strain E. coli
JM101(pUC19) not expressing VHb. When cells are grown in a special fed-batch procedure, the formation of
cytoplasmic IBs consisting of pre-13-lactamase is also inducible in the control strain. Comparative microscopic
and compositional analyses of IBs generated in E. coli JM101(pUC19) and JM101(pRED2) under identical
growth conditions strongly suggest that pre-13-lactamase and VHb coaggregate into common IBs in E. coli
JM101(pRED2).
Inclusion body (IB) formation is frequently observed
when heterologous proteins are expressed in Escherichia
coli (25, 28, 35). However, native proteins of E. coli such as
the cytoplasmic protein 0-galactosidase (8, 31) or the
periplasmic protein TEM P-lactamase (3, 4, 31) can also
aggregate into lBs. Culture conditions such as temperature
(5, 7, 29, 30, 36), pH (38, 39), substrate supply (16, 31), and
induction conditions (5, 16, 18) are known to affect in vivo
aggregation of recombinant proteins. In addition, the folding
properties of recombinant proteins influence the extent of IB
formation within the bacterial cell (11, 22). Single amino acid
substitutions can alter in vivo folding pathways and, conse-
quently, change the partition of recombinant protein into
soluble and IB fractions (17, 27, 32, 43). Finally, there is
experimental evidence that members of the chaperone pro-
tein family can facilitate correct folding and assembly of
recombinant proteins by preventing in vivo aggregation (1, 6,
10, 23, 44).
The presence of plasmid-encoded antibiotic resistance
proteins in IB preparations has been reported previously
(12, 14, 37). However, the nature of the interrelationship
between these proteins and other cloned proteins in IB
preparations remains unclear. In this study, we show that
overexpression of Vitreoscilla hemoglobin (VHb) causes
incorporation of pre-,-lactamase into cytoplasmic IBs. The
implication of expression vector design on downstream
processes is discussed.
MATERIALS AND METHODS
Bacterial strain and plasmids. E. coli JM101 and the
plasmid pUC19 are described by Yanisch-Perron et al. (45).
The plasmid pRED2 was constructed by inserting the VHb
gene under the control of its native promoter into pUC19
(15).
Cell growth. Cells were grown at 37°C in complex medium
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containing 10 g of Bacto Tryptone, 5 g of yeast extract, 5 g
of NaCl, 3 g of K2HPO4, and 1 g of KH2PO4, each per liter.
This medium was supplemented with 100 mg of ampicillin
per liter (except for JM101 cultures). Capped 2-liter flasks
(Kimax) containing 1 liter of medium each were inoculated
with 5 ml of an overnight culture. Cells were grown in a
Lab-Line Orbit Environ-Shaker at 225 rpm. After 15 h of
growth, feed medium consisting of 110 g of Bacto Tryptone,
110 g of yeast extract, and 110 g of glucose, each per liter,
was added to a final concentration of 1% (vol/vol). Growth
was continued for an additional 6 h with a reduced shaker
speed of 175 rpm. These fed-batch conditions were used as a
means of comparing pre-p-lactamase IBs generated under
identical culture conditions in E. coli JM101(pUC19) and
JM101(pRED2) [aggregation of pre-f-lactamase in E. coli
JM101(pUC19) occurs only in response to feeding in the
stationary growth phase]. Cell growth was monitored by
determining the A59 of the culture broth with a Bausch &
Lomb Spectronic 21 spectrophotometer. Samples were di-
luted appropriately to maintain the absorbance below 0.3.
Preparation of soluble and insoluble cell fractions. All
procedures were carried out at 4°C unless otherwise indi-
cated. Cells were harvested by centrifugation. Cell pellets
were resuspended in buffer A (100 mM Tris HCl [pH 8], 50
mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl fluoride) and lysed by sonication on
ice. Soluble and insoluble cell lysates were collected by
centrifugation. Details are specified in the captions to the
figures. To distinguish between membrane or membrane-
bound proteins and IBs, differential centrifugations of lysed
cells collected at the end of the cultivation were carried out.
Crude cell lysates were centrifuged at 6,000 x g for 10 min,
and the pellet fraction was collected (6,000 x g insoluble
lysate). The supematant (6,000 x g supernatant) was centri-
fuged at 12,500 x g for 15 min, and the pellet fraction was
collected (12,500 x g insoluble lysate). The remaining super-
natant (12,500 x g supernatant) was centrifuged at 26,000 x
g for 1 h, and the pellet fraction was collected (26,000 x g
insoluble lysate). The supernatant (26,000 x g supernatant)
was centrifuged at 40,000 x g for 2 h, and the pellet fraction
was collected (40,000 x g insoluble lysate). The remaining
561
562 RINAS AND BAILEY
Mr
Xl 0-3
97.4 -
66.2 -
42.7 -
31.0-
21.5 -
14.4-
A E
c
0
0')
LO)
a)
cCZ
cn0
-D
B
pUC19-
pre-I-lac
- ,-lac RNA-
1 2 3
FIG. 1. (A) SDS-PAGE analysis of total cell protein. Samples
were collected at the end of the cultivation. Cells were resuspended
in buffer A to the same absorbance. Aliquots were taken and
prepared for SDS-PAGE as described in Materials and Methods.
Lanes 1 to 3 show the total cell protein of JM101, JM101(pUC19),
and JM101(pRED2), respectively. Molecular weight markers are
shown on the left of panel A (values have already been multiplied
by 10-'). (B) Plasmid preparation of JM101(pUC19) and
JM101(pRED2). Again, cells were resuspended to the same absor-
bance. Aliquots were taken and plasmids were isolated from the cell
mixture. Plasmid DNA was digested with EcoRI and run on a 0.75%
agarose gel (lane 1). Marker DNA (1-kb DNA ladder) was from
Bethesda Research Laboratories (lane 2).
supernatant was collected as soluble cell lysate. All samples
were stored at -70°C until further analysis.
13-Lactamase assay. ,B-Lactamase activity was measured
by using ampicillin as the substrate (42). One unit of P-lac-
tamase activity was defined as 1 ,umol of ampicillin hydro-
lyzed per min at 30°C and pH 7.0.
Polyacrylamide gel electrophoresis and immunoblotting.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed by the method of Laemmli (20).
Samples were boiled for 10 min in 4% (wtlvol) SDS-20%
(wtlvol) glycerol-150 mM dithiothreitol-125 mM Tris HCl
(pH 6.8) and immediately electrophoresed on a 9 to 16%
polyacrylamide gradient gel. Gels were silver stained as
described by Hochstrasser et al. (13). Electroblotting of
proteins to nitrocellulose membranes was done by the
method described by Towbin et al. (40). Rabbit anti-TEM
P-lactamase antiserum (J. Richards, California Institute of
Technology, Pasadena) and a commercially available kit
(Vectastain ABC Kit; Vector Laboratories, Burlingame,
Calif.) were used for immunodetection of (pre)-p-lactamase.
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FIG. 2. (A) Growth data of JM1O1 (+), JM1O1(pUC19) (A), and
JM1O1(pRED2) (0); (B) profiles of active 1-lactamase formation in
JM1O1(pUC19) (A) and JM1O1(pRED2) (0). Specific P-lactamase
activities are reported as total units of enzyme corresponding to 1 ml
of culture broth that was concentrated or diluted to anA59 of 1. The
arrows indicate the time of feeding.
Immunostaining was done by the protocol of Vector Labo-
ratories.
Plasmid preparation. Plasmid preparation, restriction, and
agarose gel electrophoresis were carried out as described by
Sambrook et al. (34).
Transmission electron microscopy. Cell samples were pre-
pared as described previously (12) and examined with a
Phillips 420 transmission electron microscope.
RESULTS
E. coli JM101 carrying the plasmid pUC19 and that
carrying its derivative pRED2 were grown under identical
conditions. Both plasmids carry the bla gene encoding TEM
P-lactamase under the control of its natural promoter. The
plasmid pRED2 additionally encodes VHb. Both proteins
can aggregate into IBs or can be processed to their respec-
tive mature forms, periplasmic ,B-lactamase and dimeric
hemoglobin containing the prosthetic group protoheme IX.
When cells were grown in a fed-batch procedure as
described in Materials and Methods, mature P-lactamase
accumulated up to 1 to 2% of total cell protein in E. coli
JM101(pUC19) (Fig. 1A). However, 1-lactamase was hardly
detectable in the total cell extract of E. coli JM1O1(pRED2),
although the overall plasmid content did not seem to be
affected by the additional presence of the VHb gene and its
product (Fig. 1B). Both strains exhibited a similar growth
pattern, but the amount of j-lactamase activity produced
by JM101(pRED2) was only 15% that produced in JM101
(pUC19) (Fig. 2A and B, respectively). Gel electrophoretic
analyses of insoluble cell lysates and electron microscopy
revealed the appearance of periplasmic lBs composed of
1-lactamase in E. coli JM101(pUC19) but not in JM101
(pRED2) (Fig. 3 and 4, respectively). (It was estimated that
approximately 3% of the cells carried one or two IBs
localized in the periplasm; however, the majority appeared
to be free of IBs.) Instead, aggregation of pre-3-lactamase
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FIG. 3. Cell samples of JM101 (A), JM101(pUC19) (B), and JM101(pRED2) (C) were collected over the course of the cultivation. Cells
were resuspended to the same absorbance and lysed by sonication on ice. The insoluble lysates were prepared by centrifugation at 16,000 x
g for 30 min. Aliquots of the debris fractions were analyzed by SDS-PAGE. Lanes 1 to 7 show the insoluble lysates from 3, 6, 9, 12.5, 15,
18, and 21 h postinoculation, respectively. The insoluble lysates in lanes 6 and 7 were collected after the addition of the feed medium. The
outer membrane proteins OmpA, OmpC, and OmpF are indicated in panel A. Molecular weight markers are shown on the left of the figure
(values have already been multiplied by 10-3).
into cytoplasmic lBs was observed in E. coli JM1O1(pRED2)
(Fig. 3C and 4C). In E. coli JM1O1(pUC19), aggregation of
pre-3-lactamase into cytoplasmic lBs was observed only in
response to the addition of feed medium in the stationary
growth phase (Fig. 3B, lanes 6 and 7; Fig. 4B2). To distin-
guish between membrane-bound pre-,-lactamase and cyto-
plasmic pre-p-lactamase IBs, differential centrifugations of
lysed cells collected at the end of the fed-batch procedure
FIG. 4. Transmission electron micrographs of JM101 (A), JM101(pUC19) (B1 and B2), and JM101(pRED2) (C). Bars represent 500 nm. The
cells shown in panel B1 were collected prior to feeding; the other micrographs represent cells collected at the end of the cultivation. Periplasmic
lBs containing P-lactamase were produced in JM101(pUC19) prior to feeding (B1); cytoplasmic lBs containing pre-I-lactamase appeared after
the addition of feed medium (B2). Only cytoplasmic lBs were formed in JM101(pRED2) (C). pIB, periplasmic IBs; cIB, cytoplasmic IBs.
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FIG. 5. SDS-PAGE (A) and immunoblots (B) of soluble and
insoluble cell lysates. (A) Samples of JM101 (lanes 1, 4, and 7),
JM1O1(pUC19) (lanes 2, 5, and 8), and JM101(pRED2) (lanes 3, 6,
and 9) were collected at the end of the cultivation, resuspended to
the same absorbance, and lysed by sonication on ice. Insoluble
lysates were prepared by centrifugation of crude cell lysates at 6,000
x g for 10 min (lanes 4 to 6) and centrifugation of the remaining
supernatant at 12,500 x g for 15 min (lanes 7 to 9). Soluble lysates
were obtained as supernatants after additional centrifugations at
26,000 x g for 1 h and 40,000 x g for 2 h (lanes 1 to 3). Aliquots were
analyzed by SDS-PAGE. Insoluble fractions were concentrated four
times relative to respective soluble fractions. (B) Samples of JM101
(lane 1), JM1O1(pUC19) (lanes 2 to 4), and JM1O1(pRED2) (lanes 5 to
7) were also analyzed by immunoblotting. Soluble lysates (lanes 2 and
5) and insoluble lysates collected at 6,000 x g (lanes 3 and 6) and
12,500 x g (lanes 4 and 7) were prepared as described above. The
total cell protein of JM101 (lane 1) was concentrated two times
relative to soluble fractions. Molecular weight markers are shown on
the left of the figure (values have already been multiplied by 10-3).
were carried out. These experiments revealed that pre-0-
lactamase was completely recovered in the pellet fraction of
E. coli JM1O1(pRED2) by low-speed centrifugation (6,000 x
g insoluble lysate) (Fig. 5). Membrane fractions partly pre-
cipitated at low- and high-speed centrifugations. For exam-
ple, outer membrane proteins were present in 6,000 x g and
12,500 x g insoluble lysates (Fig. 5; outer membrane pro-
teins are labelled in Fig. 3A). Membrane-bound pre-3-
lactamase should be present in low- and high-speed pellets.
However, the absence of pre-3-lactamase in the 12,500 x g
insoluble lysate of JM1O1(pRED2) clearly demonstrated that
pre-p-lactamase was not bound to the membrane but aggre-
gated into cytoplasmic lBs. In E. coli JM1O1(pUC19), pre-
13-lactamase was recovered in 6,000 x g and 12,500 x g
insoluble lysates (Fig. 5). However, the presence of pre-,-
lactamase in 26,000 x g and 40,000 x g insoluble lysates was
not apparent on silver-stained gels (data not shown). A
minute and barely detectable amount of pre-,B-lactamase was
visualized in 26,000 x g and 40,000 x g insoluble lysates of
JM1O1(pUC19) by overstaining of the immunoblots, demon-
strating that only traces of pre-p-lactamase were present as
a membrane-bound species (data not shown). In addition,
electron micrographs clearly demonstrated the presence of
cytoplasmic inclusion bodies in JM101(pUC19) (Fig. 4B2).
A comparison of cytoplasmic lBs in E. coli JM101(pUC19)
and JM101(pRED2) by electron microscopy revealed larger
inclusion bodies in E. coli JM101(pRED2) (Fig. 4). However,
SDS-PAGE analyses revealed lower amounts of precursor in
the insoluble cell fraction of JM101(pRED2) (Fig. 3 and 5).
These results strongly suggest that pre-,B-lactamase and VHb
coaggregate into common cytoplasmic IBs. Identical resis-
tance of pre-3-lactamase and VHb to solubilization by
detergent extraction of lBs (12) additionally supports our
conclusion that the two proteins coaggregate into common
cytoplasmic lBs.
DISCUSSION
Extensive studies of folding and aggregation of (pre)-p-
lactamase within E. coli have been conducted previously (3,
4, 7, 9). However, the consequence of coexpression of
another recombinant protein on proper folding or IB forma-
tion of (pre)-,-lactamase remained undetermined. In this
study, we show that coexpression of VHb causes the incor-
poration of pre-3-lactamase into cytoplasmic IBs. Our re-
sults clearly demonstrate that, in addition to culture condi-
tions or protein folding properties, the coexpression of
another recombinant protein is a factor influencing the
extent of in vivo aggregation of a recombinant protein within
the bacterial cell. Culture conditions causing aggregation of
pre-p-lactamase in the cytoplasm of the strain coexpressing
VHb do not induce the formation of cytoplasmic pre-,-
lactamase lBs in the control strain. When cells are grown
under identical conditions, more ,3-lactamase is translocated
and processed to its mature form in the strain not expressing
VHb.
In vivo aggregation of pre-p-lactamase in the cytoplasm of
E. coli must occur in competition to translocation or to
folding (or complexing) into a translocation-competent form.
Translocation occurs posttranslationally (41), and the export
of TEM ,B-lactamase into the periplasm of E. coli is depen-
dent on a functional heat shock regulon (24). Recent work
suggested that the in vivo translocation ofTEM 1-lactamase
in E. coli is chaperoned by the heat shock proteins GroEL
and GroES (19). In vitro studies revealed that newly synthe-
sized pre-,B-lactamase associates with the GroEL protein (2)
and that the folding pathway of pre-3-lactamase is modu-
lated by the GroE heat shock proteins (21). In vitro studies
also revealed that the addition of misfolded forms of myo-
globin such as apomyoglobin or heat-denatured apomyoglo-
bin interfered with the GroEL-pre-13-lactamase interaction
(2). Thus, overexpression of VHb in JM101(pRED2), clearly
leading to misfolded forms of the globin, may deprive
pre-p-lactamase of its chaperone and prevent its folding into
a translocation-competent form. Overburdening of the pro-
tein-folding machinery caused by overexpressing VHb and
competition of VHb and pre-3-lactamase folding intermedi-
ates for mutual folding helpers may cause the incorporation
of pre-p-lactamase into cytoplasmic IBs mainly composed of
VHb. However, an overload on the protein-folding machin-
ery is also possible in the control strain, resulting in the
aggregation of pre-p-lactamase caused by its increased ex-
pression in response to the addition of feed medium.
Recovery of active proteins from IBs requiring solubiliza-
tion and refolding procedures is common practice (14, 25, 26,
33). To simplify recombinant protein purification, proteins
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arising from coprecipitation of membrane fractions such as
the outer membrane proteins are removed from crude IB
preparations by detergent extraction prior to the solubiliza-
tion and refolding procedures. However, identical resistance
of pre-3-lactamase and VHb to detergent extraction of lBs
(12) interferes with the purification of VHb prior to solubili-
zation and refolding. Although it is general opinion that the
native P-lactamase promoter is constitutive and weak, our
studies reveal that more (pre)-,B-lactamase is produced than
required to provide resistance against 1-lactam antibiotics to
cells carrying the plasmid pUC19 or its derivatives. The
observed phenomenon may also extend to other binary
expression systems, and vectors with lower expressions of
antibiotic resistance proteins should be employed to simplify
purification of the target protein produced in the form of IBs.
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